Su al.
TisB Protein Protects Escherichia coli Cells Suffering Massive DNA Damage from Environmental Toxic Compounds.
mBio. 2022 Apr 2
Hobson al.
The interplay between anticancer challenges and the microbial communities from the gut.
Eur. J. Clin. Microbiol. Infect. Dis. 2022 Mar 30
Contejean al.
Antimicrobial stewardship in high-risk febrile neutropenia patients.
Antimicrob. Resist. Infect. Control. 2022 Mar 26
Denamur al.
Genome wide association study of Escherichia coli bloodstream infection isolates identifies genetic determinants for the portal of entry but not fatal outcome.
PLoS Genet. 2022 Mar 24
Rossi al.
Large retrospective study analysing predictive factors of primary treatment failure, recurrence and death in pyogenic liver abscesses.
Infection. 2022 Mar 22
Lo al.
Simultaneous Hospital Outbreaks of New Delhi Metallo-β-Lactamase-Producing Enterobacterales Unraveled Using Whole-Genome Sequencing.
Microbiol. Spectr. 2022 Mar 21
Le Hingrat al.
Ibalizumab shows in vitro activity against group A and group B HIV-2 clinical isolates.
AIDS. 2022 Mar 8
Moby al.
Poor oral health and hygiene habits in patients with infective endocarditis and previously identified predisposing cardiac condition: A prospective cohort study.
J. Infect. 2022 Mar 2
Lingas al.
Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial.
J. Antimicrob. Chemother. 2022 Mar 2
Congo-Ouedraogo al.
Genomic and antimicrobial resistance analyses of Neisseria gonorrhoeae isolates, Burkina Faso, 2018-2019.
J. Eur. Acad. Dermatol. Venereol. 2022 Feb 28
Royer G. et al.
Reduced chlorhexidine susceptibility is associated with tetracycline resistance tet genes in clinical isolates of Escherichia coli.
Antimicrob. Agents Chemother. 2022 Feb 28
Berthod D. et al.
Are there reasons behind high Handrub consumption? A French National in-depth qualitative assessment.
Antimicrob. Resist. Infect. Control. 2022 Feb 23
Leducq V. et al.
Nosocomial transmission clusters and lineage diversity characterized by SARS-CoV-2 genomes from two large hospitals in Paris, France, in 2020.
Sci. Rep. 2022 Feb 20
Timsit J.F. et al.
Cefiderocol for the Treatment of Infections Due To Metallo-Beta-Lactamase-Producing Pathogens in the CREDIBLE-CR And APEKS-NP Phase 3 Randomized Studies.
Clin. Infect. Dis. 2022 Feb 11
Egloff C. et al.
Pregnant women’s perceptions of the COVID-19 vaccine: A French survey.
PLoS One 2022 Feb 7
Landman R. et al.
A 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trial.
Lancet HIV. 2022 Feb 1
Guyeux C. et al.
Connection between two historical tuberculosis outbreak sites in Japan, Honshu, by a new ancestral Mycobacterium tuberculosis L2 sublineage.
Epidemiol. Infect. 2022 Jan 19
de Lastours V. et al.
Evolution of fluoroquinolone-resistant Escherichia coli in the gut after ciprofloxacin treatment.
Int. J. Med. Microbiol. 2022 Jan 4
Choudhury A. et al.
High-throughput navigation of the sequence space.
New Front. and Appl. of Synth. Biology. 2022 Jan